The spectrum of resistance in SR/CR mice: The critical role of chemoattraction in the cancer/leukocyte interaction

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Riedlinger, Gregory ^a   Adams, Jonathan ^a   Stehle, John R ^a   Blanks, Michael J ^a   Sanders, Anne M ^a   Hicks, Amy M ^a   Willingham, Mark C ^a   Cui, Zheng ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOTACTIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; CANCER CELL CULTURE; CANCER RESISTANCE; CELL FREE SYSTEM; CHEMOSENSITIVITY; CHEMOTAXIS; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE MIGRATION; LUNG CARCINOMA LL 2; LYMPHOCYTIC INFILTRATION; LYMPHOMA CELL LINE; LYMPHOMA EL 4; LYMPHOMA J774; MELANOMA B16; MOUSE; MOUSE STRAIN; NONHUMAN; SARCOMA 180; SARCOMA CELL; SARCOMA METHA; SPONTANEOUS REGRESSION COMPLETE RESISTANCE MOUSE; SURFACE PROPERTY; TUMOR ESCAPE; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; LEUKOCYTE; NEOPLASM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; TUMOR CELL LINE; TUMOR REGRESSION;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; IMMUNITY, CELLULAR; IMMUNITY, INNATE; LEUKOCYTES; MICE; MICE, INBRED BALB C; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASMS; SARCOMA 180; TUMOR ESCAPE;

EID: 77955671338     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-179     Document Type: Article

References (24)

1. Koch J, Boschian A, Hau J, Rieneck K. Frequency of the cancer-resistant phenotype in SR/CR mice and the effect of litter seriation. In Vivo 2008, 22:565-569.
2. Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, Hawkins GA, Miller MS, Weir HM, Du W, DeLong CJ. Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci USA 2003, 100:6682-6687. 10.1073/pnas.1031601100, 164507, 12724523.
3. Cui Z. The winding road to the discovery of the SR/CR mice. Cancer Immun 2003, 3:14.
4. Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J, et al. Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci USA 2006, 103:7753-7758. 10.1073/pnas.0602382103, 1458507, 16682640.
5. Hicks AM, Willingham MC, Du W, Pang CS, Old LJ, Cui Z. Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice. Cancer Immun 2006, 6:11.
6. Hudig D, Ewoldt GR, Woodard SL. Proteases and lymphocyte cytotoxic killing mechanisms. Curr Opin Immunol 1993, 5:90-96. 10.1016/0952-7915(93)90086-8, 8452680.
7. Young JD, Podack ER, Cohn ZA. Properties of a purified pore-forming protein (perforin 1) isolated from H-2-restricted cytotoxic T cell granules. J Exp Med 1986, 164:144-155. 10.1084/jem.164.1.144, 2188200, 2425027.
8. Podack ER, Young JD, Cohn ZA. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci USA 1985, 82:8629-8633. 10.1073/pnas.82.24.8629, 390971, 2417226.
9. Egorov IK, Egorov OS. Detection of new MHC mutations in mice by skin grafting, tumor transplantation and monoclonal antibodies: a comparison. Genetics 1988, 118:287-298. 1203281, 2966091.
10. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21:137-148. 10.1016/j.immuni.2004.07.017, 15308095.
11. Kim R, Emi M, Tanabe K, Arihiro K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res 2006, 66:5527-5536. 10.1158/0008-5472.CAN-05-4128, 16740684.
12. Moser B, Willimann K. Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis 2004, 63(Suppl 2):ii84-ii89. 10.1136/ard.2004.028316, 1766778, 15479880.
13. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003, 102:1186-1195. 10.1182/blood-2002-12-3775, 12714508.
14. Tsou CL, Haskell CA, Charo IF. Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 2001, 276:44622-44626. 10.1074/jbc.M107327200, 11571300.
15. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 2001, 276:37993-38001.
16. Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions?. Bioessays 1999, 21:17-28. 10.1002/(SICI)1521-1878(199901)21:1<17::AID-BIES3>3.0.CO;2-4, 10070251.
17. Beck C, Schreiber H, Rowley D. Role of TGF-beta in immune-evasion of cancer. Microsc Res Tech 2001, 52:387-395. 10.1002/1097-0029(20010215)52:4<387::AID-JEMT1023>3.0.CO;2-W, 11170297.
18. Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, Mortarini R, Arancia G, Anichini A, Fais S, Parmiani G. Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction. Immunol Rev 2002, 188:97-113. 10.1034/j.1600-065X.2002.18809.x, 12445284.
19. Oble DA, Loewe R, Yu P, Mihm MC. Focus on TILs: Prognostic significance of tumor-infiltrating lymphocytes in human melanoma. Cancer Immunity 2009, 9:3.
20. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T-cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005, 102:18538-18543. 10.1073/pnas.0509182102, 1311741, 16344461.
21. Liakou CI, Narayanan S, Ng Tang D, Logothetis CJ, Sharma P. Focus on TILs: Prognostic significance of tumor-infiltrating lymphocytes in human bladder cancer. Cancer Immun 2007, 7:10.
22. Dunn GP, Dunn IF, Curry WT. Focus on TILs: Prognostic significance of tumor-infiltrating lymphocytes in human glioma. Cancer Immunity 2007, 7:12.
23. Ohtani H. Focus on TILs: Prognostic significance of tumor-infiltrating lymphocytes in human colorectal cancer. Cancer Immunity 2007, 7:4.
24. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Page's C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Page's F. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome. Science 2006, 313:1960-1964. 10.1126/science.1129139, 17008531.